Medical Automation Market Report 2023: R&D Consistency Drives Sector Growth

The global medical automation market is expected to be worth US$ 44.45 billion in 2022, growing at a CAGR of 10.6% between 2023 and 2033.

The adoption of automated equipment by pharmaceutical companies' drug discovery departments, the growth in demand for miniaturisation, and technical improvements along with the rise in demand for robot-assisted surgeries are some of the major drivers for the medical automation market.

Further contributing elements include increased government activities, a rise in clinical trials as a result of growing R&D outsourcing to emerging economies, and rising infrastructure development expenditures. For example, as a result of government initiatives in countries such as South Korea and China that promote domestic innovation, more domestic firms in the surgical automation business focus in robotic-assisted procedures. Curexo in South Korea, which also serves as the local distributor for THINK Surgical's Solution robotic system, and TINAVI Medical Technologies in China are two examples. An increase in local companies will be critical to the market's growth over the forecast period.

Key Takeaways-

  • North America held the biggest market share in the healthcare automation industry in 2021.
  • The therapeutic automation sector has the largest global market share and is expected to maintain its dominance during the forecast period.
  • Based on end users, the Research Institution sector has the largest market share in the global market.
  • By region, North America has the largest market share (41% in the worldwide healthcare automation business).
  • Yet, the Asia-Pacific medical automation business is predicted to be the fastest growing.

Competitive Landscape-

The major players in the medical automation market are-

  • Accuray, Inc.
  • Tecan Group Ltd.
  • Medtronic Plc.
  • Swisslog Holding AG
  • GE Healthcare
  • Intuitive Surgical, Inc.
  • Stryker Corporation
  • Siemens AG
  • Koninklijke Philips N.V.
  • Danaher Corporation
  • Zimmer Biomet

Browse Details Summary@ https://www.futuremarketinsights.com/reports/medical-automation-market

Key Segments Profiled in the Medical automation market Survey

By Application:

  • Imaging
  • therapeutic
  • laboratory and pharmacy
  • medical software
  • Informatics
  • logistics

By end use:

  • Hospital and diagnostic center
  • Research laboratories & institutes
  • Pharmacies
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more